NASDAQ:ENGN enGene (ENGN) Stock Price, News & Analysis $6.39 +0.24 (+3.90%) (As of 10:29 AM ET) Add Compare Share Share Today's Range$5.91▼$6.5350-Day Range$5.26▼$10.0052-Week Range$4.94▼$43.00Volume23,858 shsAverage Volume88,605 shsMarket Capitalization$282.22 millionP/E RatioN/ADividend YieldN/APrice Target$34.40 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get enGene alerts: Email Address enGene MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside459.3% Upside$34.40 Price TargetShort InterestHealthy0.18% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.00Based on 42 Articles This WeekInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($1.33) to ($1.51) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.41 out of 5 starsMedical Sector499th out of 924 stocksBiotechnology Industry8th out of 25 stocks 3.5 Analyst's Opinion Consensus RatingenGene has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageenGene has received no research coverage in the past 90 days.Read more about enGene's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.18% of the float of enGene has been sold short.Short Interest Ratio / Days to CoverenGene has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in enGene has recently decreased by 82.64%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldenGene does not currently pay a dividend.Dividend GrowthenGene does not have a long track record of dividend growth.Read more about enGene's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ENGN. Previous Next 1.1 News and Social Media Coverage News SentimentenGene has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 42 news articles for enGene this week, compared to 23 articles on an average week. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, enGene insiders have not sold or bought any company stock.Percentage Held by Insiders13.70% of the stock of enGene is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions64.16% of the stock of enGene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about enGene's insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for enGene are expected to decrease in the coming year, from ($1.33) to ($1.51) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of enGene is -3.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of enGene is -3.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Darwin2024's Must-Watch Stocks!Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now] About enGene Stock (NASDAQ:ENGN)enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.Read More ENGN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ENGN Stock News HeadlinesAugust 22 at 9:30 AM | sports.yahoo.comCM: Fofana and Pavlovic warm up their engines – Fonseca’s thinking ahead of Parma tripAugust 21 at 10:08 AM | yahoo.comColonial Belle loses engine power on the Erie Canal for hoursAugust 22, 2024 | DTI (Ad)hidden income trade in Apple?Is there a HUGE hidden income opportunity within Apple stock? Well, a brand new report suggests that is the case. And it’s all based on a “twist” on income trading hidden right inside one of the top stocks ever.August 21 at 10:08 AM | msn.comFerrari 550 Maranello Reborn: V12 Engine and 500 HP+August 21 at 10:08 AM | msn.comSick of Google? Try one of these 5 search engines insteadAugust 21 at 5:06 AM | msn.comBoeing grounds 777X fleet after test flight reveals damage to engine mountAugust 21 at 5:06 AM | msn.comSolo student pilot makes emergency landing on Wisconsin road after engine problemsAugust 21 at 5:06 AM | msn.comDodge's New Hurricrate Engine Give You 550 HP For Less Than $14,000August 22, 2024 | DTI (Ad)hidden income trade in Apple?Is there a HUGE hidden income opportunity within Apple stock? Well, a brand new report suggests that is the case. And it’s all based on a “twist” on income trading hidden right inside one of the top stocks ever.August 21 at 5:06 AM | sports.yahoo.comInside the engine room: Mac Allister and Szoboszlai shine light on Arne Slot's new set-upAugust 21 at 5:06 AM | msn.com5 Of The Most Powerful Flat-Plane V8 EnginesAugust 21 at 1:30 AM | americanbankingnews.comFinancial Survey: enGene (ENGN) vs. Its CompetitorsAugust 21 at 1:30 AM | americanbankingnews.comReviewing enGene (ENGN) and The CompetitionAugust 20 at 9:32 AM | msn.comBoeing grounds 777X test fleet after finding cracks in engine mounting structureAugust 20 at 9:32 AM | msn.comInvasive hornet nests the size of a car engine found in SC for 1st time. Why that’s a big problemAugust 20 at 9:32 AM | forbes.comBoeing’s 777X Test Fleet Grounded After Fault Found In Engine FrameAugust 20 at 9:32 AM | msn.comWhat Exactly Is The Docker Engine (And What Is It Used For)?August 20 at 9:32 AM | msn.comBoeing Halts 777X Flight Tests Over Damaged Engine MountSee More Headlines Receive ENGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for enGene and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/14/2024Today8/22/2024Fiscal Year End10/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:ENGN Previous SymbolNASDAQ:ENGN CUSIPN/A CIK1980845 Webwww.engene.com Phone302-273-0765FaxN/AEmployees31Year FoundedN/APrice Target and Rating Average Stock Price Target$34.40 High Stock Price Target$40.00 Low Stock Price Target$30.00 Potential Upside/Downside+438.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($1.63) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$104.74 million Net MarginsN/A Pretax MarginN/A Return on Equity-63.25% Return on Assets-5.65% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$3.28 per share Price / Cash Flow1.95 Book Value($0.66) per share Price / Book-9.68Miscellaneous Outstanding Shares44,166,000Free Float38,115,000Market Cap$282.22 million OptionableN/A Beta-0.63 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesDr. Alex Nichols Ph.D. (Age 38)President & COO Comp: $504.44kDr. James C. Sullivan M.Sc. (Age 45)Ph.D., Chief Scientific Officer Comp: $524.29kMr. Ronald H. W. Cooper (Age 61)Chief Executive Officer & Director Dr. Anthony T. Cheung Ph.D. (Age 52)Co-Founder & CTO Comp: $341.75kMr. John C. Brown D.Sc.FRSC, Ph.D., Co-Founder and Member of Scientific Advisory BoardMr. David Ryan Daws (Age 50)CFO & Head of Business Development Mr. Lee G. Giguere (Age 43)Chief Legal Officer & Corporate Secretary Ms. Sharon TanVP of Project Management & Head of Program ManagementDr. Raj Pruthi M.D.Chief Medical OfficerMr. Paul EricksonNon-Executive DirectorMore ExecutivesKey CompetitorsAllogene TherapeuticsNASDAQ:ALLOCingulateNASDAQ:CINGLENZ TherapeuticsNASDAQ:LENZbluebird bioNASDAQ:BLUEAllakosNASDAQ:ALLKView All CompetitorsInsiders & InstitutionsPoint72 Asset Management L.P.Sold 138,686 shares on 8/19/2024Ownership: 0.099%Perceptive Advisors LLCSold 198,888 shares on 8/16/2024Ownership: 1.811%Blue Owl Capital Holdings LPSold 11,523 shares on 8/15/2024Ownership: 5.547%Logos Global Management LPBought 400,000 shares on 8/14/2024Ownership: 2.717%Marshall Wace LLPSold 35,355 shares on 8/14/2024Ownership: 1.731%View All Insider TransactionsView All Institutional Transactions ENGN Stock Analysis - Frequently Asked Questions How have ENGN shares performed this year? enGene's stock was trading at $9.23 at the beginning of 2024. Since then, ENGN shares have decreased by 33.4% and is now trading at $6.15. View the best growth stocks for 2024 here. How were enGene's earnings last quarter? enGene Holdings Inc. (NASDAQ:ENGN) posted its quarterly earnings data on Friday, June, 14th. The company reported ($0.38) earnings per share for the quarter, missing analysts' consensus estimates of ($0.24) by $0.14. Who are enGene's major shareholders? enGene's top institutional shareholders include Blue Owl Capital Holdings LP (5.55%), Logos Global Management LP (2.72%), Perceptive Advisors LLC (1.81%) and Marshall Wace LLP (1.73%). View institutional ownership trends. How do I buy shares of enGene? Shares of ENGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ENGN) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredTrump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Chri...Preserve Gold | SponsoredThis Crypto Is Set to Explode in AugustWith the 2024 Bitcoin Halving, there's a potential HUGE bull run for altcoins. While everyone's chasing the...Crypto 101 Media | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredSilver Grab of the Decade?In a groundbreaking move, J.P. Morgan now possesses the largest amount of physical silver in recorded history…...Colonial Metals | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredThis One stock is all you need...What if you could ignore 99% of the stock market... And retire on just ONE ticker?Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enGene Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share enGene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
